Switch2System program

Want more from your insulin pump?

Switch to a MiniMed system for $499.^†With MiniMed automated insulin pump systems, you can spend less time chasing highs and lows.^‡

See if you're eligible to trade in your in-warranty pump and get a MiniMed pump system. If you decide it's not for you, you can return it within 90 days.

See if you're eligible

minimed-flex-instinct-sensor-woman-riding-bike

Why are people switching to a MiniMed system?

Freedom at mealtimes: The only automated insulin delivery systems with Meal Detection^TM technology^§ that detect rapid rises in glucose from a meal and deliver stronger auto corrections for occasional missed meal boluses or underestimated carbs.^◊
Freedom from frequent changes: As few as 6 device insertions a month^¶,# for your sensor and infusion set combined with the 15-day Instinct sensor, made by Abbott, and the 7-day Extended^TM infusion set.
Freedom to choose: Go small and app-controlled with MiniMed Flex^TM, or manage everything right from your pump with MiniMed^TM 780G system.

How the Switch2System program works

Check eligibility

Fill out the form to see if you're eligible.

Choose your MiniMed system

If eligible, switch to the MiniMed Flex or MiniMed 780G for $499.^† Payment plan options are available.

Make the switch

Start using your new MiniMed system. If it’s not right for you, you can return it within 90 days.^†

indicates a required field.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:

Sign-up to receive our newsletter for monthly updates and tips
Visit our blog to read helpful diabetes stories and perspective from the community

If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

Sign-up to receive our newsletter for monthly updates and tips
Visit our blog to read helpful diabetes stories and perspective from the community

If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

First name (of the person living with diabetes)

This field is required.

Last name (of the person living with diabetes)

This field is required.

Phone

This field is required.

ZIP code

This field is required.

Keep me updated with MiniMed offers and news

This field is required.

HIPAA Marketing Authorization

MiniMed respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors who are assisting us with these activities.

I understand that this Authorization may permit MiniMed to contact me by text message, telephone, or email. With respect to text messages, I consent to receiving text messages at the phone number(s) submitted using automated technology from or on behalf of MiniMed, concerning the marketing, advertising, and/or offers of sale of MiniMed products, therapies, and services. I also certify that I am (a) age 18 or older and (b) authorizing and consenting to use of the information provided for MiniMed to contact me. My consent is not a condition for purchase. Airtime, message, and data rates may apply. I may opt out at any time by (i) texting "STOP" in reply to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into my MiniMed myHome profile and updating my communication preferences (www.diabetes.shop/communication).

Please note that this Authorization is optional, and you may refuse to opt in. If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other MiniMed products, mobile apps, or services.

This Authorization will expire ten (10) years from the date you submit it online. You may revoke it by:

i. Email takecontrol@medtronic.com
ii. Update preferences at www.diabetes.shop/communication
iii. Call Customer Service at 800-646-4633

Opting out will not affect actions already taken. Information disclosed may be re-disclosed and no longer protected by federal privacy standards. Questions? Contact Customer Service at 800-646-4633 or takecontrol@medtronic.com.

Subscribe to our newsletter, News to Infuse

This field is required.

	MiniMed Flex^TM system MiniMed^TM 780G system	Tandem Control IQ with Dexcom G7®	Beta Bionics® iLet with Dexcom G7®
Meal Detection^TM technology^§ Helps correct for rising glucose after meals
Auto correction bolus^◊	Every 5 mins Up to 8% of the TDD^∆	Every 60 mins Limited to 6 units^∞	Every 5 mins Limited to 3 units^∞
Automated basal delivery every 5 minutes
Time between site changes	7 days	3 days	3 days
Flexible glucose target as low as 100 mg/dL
Max insulin capacity	300 units	200 units (Mobi) 300 units (Tslim)	180 units

Switch to MiniMed

I didn't realize how much mental energy I was spending on diabetes every day. The biggest difference since using MiniMed is peace of mind."

Abby

MiniMed Champion

MiniMed Flex system

Frequently asked questions

How long do I have to try the MiniMed system?

Through the Switch2System program, you have 90 days to return either the MiniMed pump or the pump from another company.

What if I can’t pay the fee right now?

The Switch2System program is eligible for our payment program, allowing you to split up the fee and pay as little as $50/month. A service fee may apply. A member of our team will be happy to discuss your options and provide more details.

Do I need to return my trade-in pump while I try the MiniMed system?

When you decide you want to stay on the MiniMed system, then you will be required to send in your current pump.

Can I choose between MiniMed Flex^TM and MiniMed^TM 780G system?

Yes. If you’re eligible for the Switch2System program, you can choose either the MiniMed Flex or MiniMed 780G insulin pump system that works best for you.

How much does the Switch2System program cost?

The Switch2System program is $499.^† It includes your MiniMed pump, one month of pump supplies, and, for eligible customers, one month of sensors. If you can’t pay it all at once, you may be eligible to pay as little as $50/month.

Do I need to return my current pump right away?

No. You can keep your current pump at first. If you decide to stay with MiniMed, you’ll need to return your trade-in pump within 90 days of when your MiniMed pump ships.

What if I decide my new MiniMed system isn’t right for me?

You have up to 90 days from the date your MiniMed system ships to return it.

Who is eligible for the Switch2System program?

You may qualify if you use a pump from another company and have more than 6 months left on your pump warranty. Other rules may apply.

Footnotes
† Terms and conditions apply.
‡ Refers to SmartGuard^TM feature. Individual results may vary.
§ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
◊ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
¶ Based on usage of 2 Instinct sensors for 15 days each and 4 Extended Infusion Sets for 7 days each in a one-month period. More insertions may be required if Instinct sensor or Extended infusion set requires replacement before specified wear time.
#Fingersticks required in manual mode & to enter SmartGuard^TM. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard^TM.

1. Switch2System Program Terms and conditions

Customers with more than six months remaining on their competitive pump warranty (or 5-year Medicare guideline) are eligible for the Switch2System Program.
A $499 payment will be required to use this program. This price includes one (1) insulin pump, one (1) compatible transmitter, one (1) month of consumables and one (1) month of sensors.
Customers enrolled in federal, state, or government-funded healthcare plans are excluded from receiving a transmitter and sensors from this program and cannot participate in a payment plan.
An ABN will be required to utilize this program for all Medicare customers.
Customers may return product that has been shipped as part of this program up to 90 days from the date of shipment.
Customers must return their competitor pump or receiver within 90 days. Customers who do not return their pump will be charged $4,500.
This program does not extend the warranty period of the replaced pump. The customer’s current pump warranty timeline will not change by purchasing a pump through this program.
Customers should verify that their insurance provider will support transitioning to the new pump, as it could affect ongoing coverage of their future pump supplies.
Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by MiniMed and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available information any information that MiniMed may provide concerning the discount.
MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your
Healthcare Provider regarding indications for use.
A valid prescription will be required to purchase a pump, CGM and supplies. Other restrictions may apply.
Medicare customers within a 13-month rental period cannot participate in this program.
Customers using Kaiser health plans are excluded from this program.
Pricing, terms, and conditions are subject to change at any time and without notice.

Important Safety Information: MiniMed Flex^TM system with SmartGuard^TM technology with Simplera Sync^TM sensor

The MiniMed Flex^TMsystem is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex^TM system includes SmartGuard^TM technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Simplera Sync^TM sensor can be used one time and has a life up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.

The Simplera Sync^TM sensor is not intended to be used directly to make therapy adjustments while the MiniMed Flex^TM system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync^TM sensor. The Simplera Sync^TM sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Simplera Sync^TM sensor in the abdomen or other body sites, including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

The Medtronic MiniMed Flex^TM System consists of the following devices: MiniMed Flex^TM Insulin Pump and the Simplera Sync^TMsensor. The system requires a prescription from a healthcare professional.

WARNING: Do not use the SmartGuard^TM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard^TM feature.

WARNING: Do not use the MiniMed Flex^TM system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex^TM system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard^TM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex^TM system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://link.minimed.com/Risks.

Important Safety Information: MiniMed^TM 780G system with SmartGuard^TMtechnology with Instinct sensor, Simplera Sync^TMsensor, and Guardian^TM4 sensor

The MiniMed^TM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMed^TM 780G System includes SmartGuard^TM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync^TM and Guardian^TM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuard^TMfeature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard^TMfeature.

WARNING: Do not use MiniMed^TM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMed^TM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard^TMfeature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed^TM780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://link.minimed.com/Risks.

©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. ^TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMed^TM 780G system algorithm includes technology developed by DreaMed Diabetes.

Want more from your insulin pump?

Why are people switching to a MiniMed system?

How the Switch2System program works

Check your eligibility

How long do I have to try the MiniMed system?

What if I can’t pay the fee right now?

Do I need to return my trade-in pump while I try the MiniMed system?